Anthropic launches Claude Science, Google and OpenAI racing to compete (techfundingnews.com)

Anthropic has unveiled Claude Science, a comprehensive workspace designed specifically for scientific and pharmaceutical research, aimed at streamlining the workflow of scientists who typically juggle multiple tools. This launch comes on the heels of similar offerings from Google and OpenAI, marking a competitive push among the tech giants to claim a share of the scientific research market. Claude Science integrates existing research packages, facilitates reproducibility with clear documentation and adjustable computational power, and utilizes NVIDIA’s BioNeMo Toolkit to incorporate specialized life-science models. The significance of Claude Science lies not only in its utility but also in Anthropic's immediate application of the tool for drug discovery related to neglected tropical diseases, an area often overlooked by commercial entities. This competitive landscape is further intensified as all three companies—Anthropic, Google, and OpenAI—race for the allegiance of researchers, particularly as they prepare for potential IPOs. The unique focus of Claude Science on infrastructure for diseases with limited commercial interest sets Anthropic apart and underscores its commitment to impactful research, which may be less easily replicated by competitors.